Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Sep;107(1):73–77. doi: 10.1111/j.1476-5381.1992.tb14465.x

Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.

G Grigoriadis 1, A G Stewart 1
PMCID: PMC1907628  PMID: 1330167

Abstract

1. Platelet-activating factor (PAF) binds with high affinity to albumin leading Clay et al. (1990) to suggest that the active form of PAF is the albumin-PAF complex. 2. In the present study the proposal that albumin-bound, rather than monomeric PAF, is the active form of PAF at PAF receptors was critically evaluated by examining the effect of albumin on the potency of PAF in isolated platelets and macrophages. 3. Bovine serum albumin inhibited concentration-dependently PAF-induced responses in platelets and macrophages. The most probable explanation of this finding is that BSA reduced the concentration of free PAF. 4. Thus, we conclude that free PAF, rather than the albumin-PAF complex is the active form. Consequently, local concentrations of albumin will influence profoundly the potency of endogenously released PAF. Moreover, estimates of the affinity of PAF for PAF receptors made in buffers containing BSA, underestimate the true affinity of PAF for its receptors by approximately 3 orders of magnitude.

Full text

PDF
73

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banks J. B., Wykle R. L., O'Flaherty J. T., Lumb R. H. Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol. Biochim Biophys Acta. 1988 Jul 1;961(1):48–52. doi: 10.1016/0005-2760(88)90129-4. [DOI] [PubMed] [Google Scholar]
  2. Benveniste J., Henson P. M., Cochrane C. G. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med. 1972 Dec 1;136(6):1356–1377. doi: 10.1084/jem.136.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  4. Cabot M. C., Blank M. L., Welsh C. J., Horan M. J., Cress E. A., Snyder F. Metabolism of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by cell cultures. Life Sci. 1982 Dec 20;31(25):2891–2898. doi: 10.1016/0024-3205(82)90680-4. [DOI] [PubMed] [Google Scholar]
  5. Clay K. L., Johnson C., Henson P. Binding of platelet activating factor to albumin. Biochim Biophys Acta. 1990 Oct 1;1046(3):309–314. doi: 10.1016/0005-2760(90)90246-t. [DOI] [PubMed] [Google Scholar]
  6. Grigoriadis G., Stewart A. G. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Br J Pharmacol. 1991 Sep;104(1):171–177. doi: 10.1111/j.1476-5381.1991.tb12403.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heinsohn C., Polgar P., Fishman J., Taylor L. The effect of bovine serum albumin on the synthesis of prostaglandin and incorporation of [3H]acetate into platelet-activating factor. Arch Biochem Biophys. 1987 Sep;257(2):251–258. doi: 10.1016/0003-9861(87)90564-9. [DOI] [PubMed] [Google Scholar]
  8. Hwang S. B. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J Lipid Mediat. 1990 May-Jul;2(3-4):123–158. [PubMed] [Google Scholar]
  9. Iñarrea P., Gomez-Cambronero J., Nieto M., Crespo M. S. Characteristics of the binding of platelet-activating factor to platelets of different animal species. Eur J Pharmacol. 1984 Oct 15;105(3-4):309–315. doi: 10.1016/0014-2999(84)90623-x. [DOI] [PubMed] [Google Scholar]
  10. Johnston R. B., Jr, Godzik C. A., Cohn Z. A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med. 1978 Jul 1;148(1):115–127. doi: 10.1084/jem.148.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ludwig J. C., Hoppens C. L., McManus L. M., Mott G. E., Pinckard R. N. Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. Arch Biochem Biophys. 1985 Sep;241(2):337–347. doi: 10.1016/0003-9861(85)90555-7. [DOI] [PubMed] [Google Scholar]
  12. Spector A. A. Fatty acid binding to plasma albumin. J Lipid Res. 1975 May;16(3):165–179. [PubMed] [Google Scholar]
  13. Stewart A. G., Dusting G. J. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Br J Pharmacol. 1988 Aug;94(4):1225–1233. doi: 10.1111/j.1476-5381.1988.tb11642.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tokumura A., Yoshida J., Maruyama T., Fukuzawa K., Tsukatani H. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. Thromb Res. 1987 Apr 1;46(1):51–63. doi: 10.1016/0049-3848(87)90206-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES